Assessment of glioma proliferation using imaging modalities

Journal of Clinical Neuroscience

Volumn 17, Issue 10, 2010, Pages 1233-1238

  Alexiou, George A ^a   Tsiouris, Spyridon ^a   Kyritsis, Athanasios P ^a   Argyropoulou, Maria I ^a   Voulgaris, Spyridon ^a   Fotopoulos, Andreas D ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Glioma; MRI; PET; Proliferation; SPECT

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201;

CELL PROLIFERATION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOMA; HUMAN; IMMUNOHISTOLOGY; NEUROIMAGING; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY;

CELL PROLIFERATION; DIAGNOSTIC IMAGING; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955660668     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.03.021     Document Type: Review

References (59)

1. A. Quiones-Hinojosa, N. Sanai, and J.S. Smith Techniques to assess the proliferative potential of brain tumors J Neurooncol 74 2005 19 30
2. R. Prayson The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms Adv Anat Pathol 12 2005 144 148
3. P.E. McKeever, D.A. Ross, and M.S. Strawderman A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters J Neuropathol Exp Neurol 56 1997 798 805
4. H. Wakimoto, M. Aoyagi, and T. Nakayama Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77 1996 373 380
5. T. Hoshino, D. Ahn, and M.D. Prados Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling Int J Cancer 53 1993 550 555
6. P.K. Sallinen, H.K. Haapasalo, and T. Visakorpi Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S phase fraction using archival paraffin-embedded samples J Pathol 174 1994 275 282
7. M. Watanabe, R. Tanaka, and N. Takeda Magnetic resonance imaging and histopathology of cerebral gliomas Neuroradiology 34 1992 463 469
8. O. Tynninen, H.J. Aronen, and M. Ruhala MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation Invest Radiol 34 1999 427 434
9. T.W. Stadnik, C. Chaskis, and A. Michotte Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings AJNR Am J Neuroradiol 22 2001 969 976
10. P.W. Schaefer, Y. Ozsunar, and J. He Assessing tissue viability with MR diffusion and perfusion imaging AJNR Am J Neuroradiol 24 2003 436 443
11. D. Le Bihan, P. Douek, and M. Argyropoulou Diffusion and perfusion magnetic resonance imaging in brain tumors Top Magn Reson Imaging 5 1993 25 31
12. J.A. Brunberg, T.L. Chenevert, and P.E. McKeever In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres AJNR Am J Neuroradiol 16 1995 361 371
13. S. Lu, D. Ahn, and G. Johnson Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index Radiology 232 2004 221 228
14. R. Kiss, O. Dewitte, and C. Decaestecker The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors Am J Clin Pathol 107 1997 321 331
15. S. Higano, X. Yun, and T. Kumabe Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis Radiology 241 2006 839 846
16. J.A. Calvar, F.J. Meli, and C. Romero Characterization of brain tumors by MRS, DWI and Ki-67 labeling index J Neurooncol 72 2005 273 280
17. T. Beppu, T. Inoue, and Y. Shibata Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors J Neurooncol 63 2003 109 116
18. H.J. Aronen, and J. Perkiö Dynamic susceptibility contrast MRI of gliomas Neuroimaging Clin N Am 12 2002 501 523
19. T. Noguchi, T. Yoshiura, and A. Hiwatashi Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density AJNR Am J Neuroradiol 29 2008 688 693
20. N. Sadeghi, I. Salmon, and C. Decaestecker Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma AJNR Am J Neuroradiol 28 2007 455 461
21. M.D. Jenkinson, D.G. Du Plessis, and C. Walker Advanced MRI in the management of adult gliomas Br J Neurosurg 21 2007 550 561
22. L.S. Hollingworth, R.E. Medina, and D.K. Lenkinski A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors AJNR Am J Neuroradiol 27 2006 1404 1411
23. G. Barbarella, R. Ricci, and G. Pirini In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS Int J Oncol 12 1998 461 468
24. H. Shimizu, T. Kumabe, and R. Shirane Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas AJNR Am J Neuroradiol 21 2000 659 665
25. A. Matsumura, T. Isobe, and I. Anno Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study J Clin Neurosci 12 2005 416 420
26. T. Tamiya, K. Kinoshita, and Y. Ono Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas Neuroradiology 42 2000 333 338
27. J. Chen, S.L. Huang, and T. Li In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry Neuroradiology 48 2006 312 318
28. T.R. McKnight, K.R. Lamborn, and T.D. Love Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas J Neurosurg 106 2007 660 666
29. R. Guillevin, C. Menuel, and H. Duffau Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas J Neurooncol 87 2008 181 187
30. W.D. Kaplan, T.N. Takvoria, and J.H. Morris Thallium-201 brain imaging: a comparative study with pathological correlation J Nucl Med 1987 28
31. N. Oriuchi, M. Tamura, and T. Shibazaki Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities J Nucl Med 34 1993 2085 2089
32. M. Ishibashi, A. Taguchi, and Y. Sugita Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen J Nucl Med 36 1995 2201 2206
33. F. Gungor, H. Bezircioglu, and G. Guven Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours Nucl Med Commun 21 2000 803 810
34. M.L. Chiu, J.F. Kronauge, and D. Piwnica-Worms Effect of mitochondrial and plasma membrane potential on accumulation of hexakis (2- methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts J Nucl Med 31 1990 1646 1653
35. S. Nagamachi, S. Jinnouchi, and K. Nabeshima The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma - a comparative study with 201Tl Neuroradiology 43 2001 1023 1030
36. I. Ak, Z. Gulbas, and F. Altinel Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors Clin Nucl Med 28 2003 29 33
37. N. Le Jeune, N. Perek, and D. Denoyer Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells Cancer Biother Radiopharm 20 2005 249 259
38. N. Le Jeune, N. Perek, and D. Denoyer Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells Cancer Biother Radiopharm 19 2004 411 421
39. G.A. Alexiou, S. Tsiouris, and A. Goussia Evaluation of glioma proliferation by 99mTc-Tetrofosmin Neuro-Oncol 10 2008 104 105
40. G.A. Alexiou, S. Tsiouris, and G. Vartholomatos Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-Tetrofosmin SPECT uptake Clin Neurol Neurosurg 111 2009 808 811
41. D. Denoyer, N. Perek, and N. Le Jeune Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines Eur J Nucl Med Mol Imaging 31 2004 77 84
42. D. Denoyer, N. Perek, and N. Le Jeune Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines Eur J Nucl Med Mol Imaging 32 2005 820 827
43. S. Tsiouris, I. Pirmettis, and T. Chatzipanagiotou Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V) DMSA] brain scintitomography-a plausible non-invasive depicter of glioblastoma proliferation and therapy response J Neurooncol 85 2007 291 295
44. T. Kuwert, S. Probst-Cousin, and B. Woesler Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity J Nucl Med 38 1997 1551 1555
45. A.F. Shields, J.R. Grierson, and S.M. Kozawa Development of labeled thymidine analogs for imaging tumor proliferation Nucl Med Biol 23 1996 17 22
46. 18F] FLT for imaging of cellular proliferation in vivo Nucl Med Biol 27 2000 143 156
47. S.J. Price, T.D. Fryer, and M.C. Cleij Imaging regional variation of cellular proliferation in gliomas using 3′-deoxy-3′-[18F] fluorothymidine positron-emission tomography: an image-guided biopsy study Clin Radiol 64 2009 52 63
48. R. Ullrich, H. Backes, and H. Li Glioma proliferation as assessed by 3′-fluoro-3′-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma Clin Cancer Res 14 2008 2049 2055
49. W. Chen, T. Cloughesy, and N. Kamdar Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG J Nucl Med 46 2005 945 952
50. M. Muzi, A.M. Spence, and F. O'Sullivan Kinetic analysis of 3-deoxy-3-18F-fluorothymidine in patients with gliomas J Nucl Med 47 2006 1612 1621
51. S.J. Choi, J.S. Kim, and J.H. Kim [18F]3′-deoxy-3′- fluorothymidine PET for the diagnosis and grading of brain tumors Eur J Nucl Med Mol Imaging 32 2005 653 659
52. T. Saga, H. Kawashima, and N. Araki Evaluation of primary brain tumors with FLT-PET: usefulness and limitations Clin Nucl Med 31 2006 774 780
53. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining Neurosurg Rev 22 1999 210 214
54. 18F-FDG PET Eur J Nucl Med Mol Imaging 29 2002 176 182
55. S. Kim, J.K. Chung, and S.H. Im 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET Eur J Nucl Med Mol Imaging 32 2005 52 59
56. T. Kato, J. Shinoda, and N. Nakayama Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography AJNR Am J Neuroradiol 29 2008 1176 1182
57. T. Hatakeyama, N. Kawai, and Y. Nishiyama 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma Eur J Nucl Med Mol Imaging 35 2008 2009 2017
58. P.E. Ricci, J.P. Karis, and J.E. Heiserman Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19 1998 407 413
59. W.C. Olivero, S.C. Dulebohn, and J.R. Lister The use of PET in evaluating patients with primary brain tumors: is it useful? J Neurol Neurosurg Psychiatry 58 1995 250 252